Implant Maker ConforMIS Jumps a Third on IPO
ConforMIS shares began trading Wednesday morning at $18 and popped to a high of $20.42 before pulling back.
Archive
Year: 2015
All Year: 2015 Articles
Newest first · Page 305What Has Lit a Fire Under Chubb Shares
Ace and Chubb have announced that they entered into a definitive agreement in which former will acquire the latter.
Trump Dumped by Macy’s Over Immigration Flap
Add Macy's to the lineup of companies that have announced an end to their business relationship with real-estate developer, celebrity and Republican presidential candidate Donald Trump.
Puerto Rico vs. Greece
It is no coincidence that Puerto Rico publicly admitted its debts could not be repaid at the same time that Greece technically defaults to the International Monetary Fund.
IPO of Zynerba Pharmaceuticals Targets Cannabinoid Therapeutics
Zynerba Pharmaceuticals has filed with the U.S. Securities and Exchange Commission for its initial public offering (IPO).
GM Monthly Sales Tumble in June
General Motors total June sales reflect weaker Chevrolet, Buick and Cadillac brand sales but an increase in GMC sales.
Crude Oil Price Dips as Inventory Climbs
U.S. commercial crude inventories increased by 2.4 million barrels last week, according to the EIA.
What the Harris Post-Merger Reorganization Means for Shareholders
Harris has joined the lineup of companies looking to reorganize their corporate structure. 24/7 Wall St. wanted to show a heads and tails view of the move here.
Atara Biotherapeutics Files for IPO
Atara Biotherapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Cost of July Barbecue Soars
As we approach the Fourth of July, people are stocking up on fireworks and revving up their barbecue pits. Has anyone stopped to think about how much this costs?
Teladoc Debuts Strong in IPO
Teladoc was set to be the first initial public offering (IPO) of its kind. The company claims to be the first and largest telehealth provider in the nation.
Ford Sales Rise in June, but Pickup Sales Still Faltering
Ford on Tuesday posted a U.S. sales increase of 2% year-over-year in June and truck sales declined 0.7% for the month.
Can Aldeyra Therapeutics Shares Double?
Corey Davis and Lidia Liu of Canaccord Genuity started Aldeyra Therapeutics with a Buy rating and they issued a $16.00 price target.
UBS Makes Changes to Its Equity Focus List
UBS has updated the stocks within its highly regarded Equity Focus List that have been working the best for investors over the past month and could continue to lead the portfolio.
Ford F-150 Sales Continue to Collapse
After repeated assurances that sales of Ford's flagship F-150 would rise as production of the new generation model came online, the opposite held true in June.